Cardiovascular disease (CVD) causes 3.9 million deaths in Europe every year. It is one of society’s biggest challenges as well as a significant economic burden; with an estimated cost to the EU of over €210 billion per year. EIT Health actively supports the development of innovations that aim to improve cardiac health. This varies from preventative measures to aid cardiovascular disease management, projects dedicated to the promotion of healthy living to keep hearts healthy, and solutions that can be used to detect disease and help diagnosed patients to manage their condition. EIT Health finds new ways of addressing the growing challenge of CVD by collaborating with healthcare’s leading players to design and develop innovative solutions, programmes, and initiatives, as well as creating and scaling the most promising new companies all working together to fight this pressing health burden. CEO of EIT Health, Jan-Philipp Beck said: “EIT Health believes innovation is the answer to some of the challenges posed by CVD, and strives to support transformational solutions to aid optimal prevention, treatment and management. We bring together the brightest minds from the worlds of business, research and education to accelerate cutting-edge advancements, putting innovation in the hands of those who may benefit.”.